ei ole lubatud
ei ole lubatud
Digitaalõiguste kaitse (DRM)
Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).
Vajalik tarkvara
Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)
PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )
Seda e-raamatut ei saa lugeda Amazon Kindle's.
Chapter 1: Structure and Classification of RNA viruses
Chapter 2: RNA viruses with CNS tropism
Chapter 3: Common Neuropathological features of RNA viruses
Chapter 4: Molecular and cellular alterations underlying neurological outcomes in HIV infection
Chapter 5: Zika virus and CNS
Chapter 6: Neuropathological outcomes in human influenza and respiratory syncytial virus infections
Chapter 7: The vascular route as a possible gateway for central nervous system pathology in SARS-CoV-2 infection
Chapter 8: Mechanisms for entry of RNA viruses into the CNS
Chapter 9: RNA sequencing as a powerful tool to capture virus-induced changes
Chapter 10: Novel methods and technologies for efficient detection of RNA viruses in the human brain
Chapter 11: An insight into the symptomatic treatment modalities for COVID -19
Chapter 12: Innovations in RNA therapeutics and sequencing technology to combat future viral pandemics
Chapter 13: Innovative Therepeutic Efforts for Tackling Future Viral Pandemics